Evangelos Giamarellos-Bourboulis
Evangelos Giamarellos-Bourboulis
Email verificata su
Citata da
Citata da
Complex immune dysregulation in COVID-19 patients with severe respiratory failure
EJ Giamarellos-Bourboulis, MG Netea, N Rovina, K Akinosoglou, ...
Cell host & microbe 27 (6), 992-1000. e3, 2020
mTOR-and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity
SC Cheng, J Quintin, RA Cramer, KM Shepardson, S Saeed, V Kumar, ...
science 345 (6204), 1250684, 2014
Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
S Saeed, J Quintin, HHD Kerstens, NA Rao, A Aghajanirefah, F Matarese, ...
science 345 (6204), 1251086, 2014
Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes
J Quintin, S Saeed, JHA Martens, EJ Giamarellos-Bourboulis, DC Ifrim, ...
Cell host & microbe 12 (2), 223-232, 2012
Azithromycin: mechanisms of action and their relevance for clinical applications
MJ Parnham, VE Haber, EJ Giamarellos-Bourboulis, G Perletti, ...
Pharmacology & therapeutics 143 (2), 225-245, 2014
A guiding map for inflammation
MG Netea, F Balkwill, M Chonchol, F Cominelli, MY Donath, ...
Nature immunology 18 (8), 826-831, 2017
Two phase 3 trials of adalimumab for hidradenitis suppurativa
AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ...
New England Journal of Medicine 375 (5), 422-434, 2016
Swarm learning for decentralized and confidential clinical machine learning
S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ...
Nature 594 (7862), 265-270, 2021
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
SC Cheng, BP Scicluna, RJW Arts, MS Gresnigt, E Lachmandas, ...
Nature immunology 17 (4), 406-413, 2016
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, ...
The Lancet Respiratory Medicine 9 (6), 622-642, 2021
Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection
MG Netea, EJ Giamarellos-Bourboulis, J Domínguez-Andrés, N Curtis, ...
Cell 181 (5), 969-977, 2020
What causes hidradenitis suppurativa?
L Ralf Paus, H Kurzen, I Kurokawa, GBE Jemec, L Emtestam, K Sellheyer, ...
Experimental dermatology 17 (5), 455-456, 2008
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ...
Nature medicine 27 (10), 1752-1760, 2021
TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans
B Ferwerda, MBB McCall, S Alonso, EJ Giamarellos-Bourboulis, ...
Proceedings of the National Academy of Sciences 104 (42), 16645-16650, 2007
Carrier systems for the local delivery of antibiotics in bone infections
K Kanellakopoulou, EJ Giamarellos-Bourboulis
Drugs 59, 1223-1232, 2000
Effect and safety of meropenem–vaborbactam versus best-available therapy in patients with carbapenem-resistant Enterobacteriaceae infections: the TANGO II randomized clinical trial
RG Wunderink, EJ Giamarellos-Bourboulis, G Rahav, AJ Mathers, ...
Infectious diseases and therapy 7 (4), 439-455, 2018
Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity
CC Zouboulis, T Tzellos, A Kyrgidis, GBE Jemec, FG Bechara, ...
British Journal of Dermatology 177 (5), 1401-1409, 2017
Activate: randomized clinical trial of BCG vaccination against infection in the elderly
EJ Giamarellos-Bourboulis, M Tsilika, S Moorlag, N Antonakos, A Kotsaki, ...
Cell 183 (2), 315-323. e9, 2020
Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritis
LAB Joosten, MG Netea, E Mylona, MI Koenders, RKS Malireddi, ...
Arthritis & Rheumatism 62 (11), 3237-3248, 2010
Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis
E Karakike, EJ Giamarellos-Bourboulis
Frontiers in immunology 10, 428603, 2019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20